Strides Pharma Science Ltd - Multiyear Breakout returns -2-3X !!
Updated
The price consolidation for last 9 years gave a breakout which retested the breakout levels and going upwards. The price may move to give high returns in coming time.
Technically Multiyear breakout (double bottom) and may rise the price to give multibagger return after short consolidation.
Stock details
Sector: Pharma
Theme play out: CDMO ( Contract Development and Manufacturing Organization)
Technical analysis details
Accumulation Zone= 1350-1675
Low-risk entry price = weekly closing candle >1675
Stoploss = 1235 (weekly closing for less risk takers)
Stoploss = 1000 (weekly closing below- high-risk takers)
Target 1 = 2000
Target 2 = 2500
Target 3 = 3000
Target 4 = 4500 (Time frame ~ 1-4 years)
Positives
FII holding = 30.08%
DII Holding = 18.24%
sales are increasing annually
CDMO theme
Negatives
Promoters sold their holding 4.67 % for the last 3 years
Promoters pledge to hold 49.2%
Debt > reserves
Disclaimer: This analysis is just for educational purpose; nothing is guaranteed;
Technically Multiyear breakout (double bottom) and may rise the price to give multibagger return after short consolidation.
Stock details
Sector: Pharma
Theme play out: CDMO ( Contract Development and Manufacturing Organization)
Technical analysis details
Accumulation Zone= 1350-1675
Low-risk entry price = weekly closing candle >1675
Stoploss = 1235 (weekly closing for less risk takers)
Stoploss = 1000 (weekly closing below- high-risk takers)
Target 1 = 2000
Target 2 = 2500
Target 3 = 3000
Target 4 = 4500 (Time frame ~ 1-4 years)
Positives
FII holding = 30.08%
DII Holding = 18.24%
sales are increasing annually
CDMO theme
Negatives
Promoters sold their holding 4.67 % for the last 3 years
Promoters pledge to hold 49.2%
Debt > reserves
Disclaimer: This analysis is just for educational purpose; nothing is guaranteed;
Trade active
one More Negative: Stock P/E is higher than average industry P/E
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.